Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Long Life Unlimited
WARNING LETTER
•Long Life Unlimited•January 31, 2018

Long Life Unlimited – FDA Warning Letter, Jan 31, 2018

Record Details

The FDA issued a Warning Letter to Long Life Unlimited, LLC, after reviewing their website in January 2018. The FDA determined that products sold, including Balance 600, D-Limonene, Rapha Remedy, and others, are unapproved new drugs and misbranded under the Federal Food, Drug, and Cosmetic Act.

The products are deemed drugs because website claims, such as those for Balance 600 reducing high cholesterol and stabilizing blood sugar, D-Limonene treating cancer and acid reflux, and Rapha Remedy addressing various skin conditions and infections, indicate intent for use in the cure, mitigation, treatment, or prevention of disease, or to affect body structure/function. The "Cancer Protocol" webpage and customer testimonials further support these claims.

These products are considered "new drugs" because they are not generally recognized as safe and effective for their claimed uses, requiring prior FDA approval which they lack. Additionally, they are misbranded because they fail to bear adequate directions for use by a layperson, as their intended uses (e.g., diabetes, cancer, MRSA) require supervision by a licensed practitioner.

The FDA requires Long Life Unlimited, LLC to take prompt action to correct these violations. The company must notify the FDA in writing within fifteen working days of the specific steps taken to correct the violations, including supporting documentation. Failure to comply may result in enforcement actions such as seizure or injunction.

Company
Long Life Unlimited
Inspection date
January 31, 2018
Product type
Drugs
Office
Cincinnati District Office
Person
  • Kimberly L. McMillan (Acting Program Director)
View Company Profile

ID · 64432670-eb45-47fd-af8e-913dd4b56cfa

Violation Codes9
21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)(C)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 CFR 201.521 U.S.C. 353(b)(1)(A)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Long Life Unlimited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.